Crossmark

Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration

Published Online: 2023-07-14

Authors

Yeom, Hoseok

Kwon, Hye Ji

Kim, Yoon Jeon

Lee, Junyeop

Yoon, Young Hee

Lee, Joo Yong
License Information

Text and Data Mining valid from 2023-07-14

Version of Record valid from 2023-07-14
More Information

Article History

Received: 28 February 2023

Accepted: 4 July 2023

First Online: 14 July 2023

Competing interests

: The authors declare no competing interests.

Document is current